This is the authors' abstract. We don't add key points for this paper.
Preharvest treatments with MeJA could be a promising tool to improve pomegranate crop yield, fruit quality and its content in bioactive compounds at harvest and during storage. The higher effects were obtained with MeJA at 5 mmol L⁻¹ dose, which could be the selected treatment for practical application purposes.
No takes yet. Share an insight, caveat, or question.
García-Pastor et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: